Profile picture
Données administratives

Li Tang

li.tang@epfl.ch http://tang-lab.epfl.ch/

EPFL STI IBI-STI LBI
MED 1 2826 (Bâtiment MED)
Station 9
1015 Lausanne

EPFL STI IMX-GE
MED 1 2826 (Bâtiment MED)
Station 9
1015 Lausanne

Publications représentatives

The type 2 cytokine Fc–IL-4 revitalizes exhausted CD8 T cells against cancer


Published in Nature in 2024

Single-cell CAR T atlas reveals type2 function in 8-year leukemia remission


Published in Nature in 2024

IL-10-expressing, anti-CD19 CAR T cells for patients with relapsed or refractory B-cell acute lymphoblastic leukaemia: an open-label, single-arm, phase 1 study


Published in The Lancet Haematology in 2025

IL-10-expressing CAR T cells resist dysfunction and mediate durable clearance of solid tumors and metastases


Published in Nature Biotechnology in 2024

Metabolic reprogramming of terminally exhausted CD8 T cells by IL-10 enhances anti-tumor immunity


Published in Nature Immunology in 2021

Cancer-cell stiffening via cholesterol depletion enhances adoptive T-cell immunotherapy


Published in Nature Biomedical Engineering in 2021

Switchable immune modulator for tumor-specific activation of anticancer immunity


Published in Science Advances in 2021

Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery


Published in Nature Biotechnology in 2018

Evidence and therapeutic implications of biomechanically regulated immunosurveillance in cancer and other diseases


Published in Nature Nanotechnology in 2024

Enseignement et PhD

Doctorant·es actuel·les

Yunyi Zhou, Weilin Li, Tom Enbar, Zuzanna Dorota Krawczyk

A dirigé les thèses EPFL de

Yuqing Xie (2022), Kewen Lei (2022), Yang Zhao (2023), Min Gao (2023), Xiaomeng Hu (2023), Armand Kurum (2024), Lucia Bonati (2025), Rongrong Li (2026)

A co-dirigé les thèses EPFL de

Lixia Wei (2022), Céline Jasmin Prange (2023), Nadia Yasmina Ben Sayed (2026), Yann Tinguely (2026)